Scientists identify aggressive pancreatic cancer cells and their vulnerability

No Comment 0 View

A series of preclinical experiments using patient-derived tumor xenografts (PDXs) and mouse models point to potential treatments for patients with a rapidly-progressing and resistant subgroup of tumor cells.



Source link

In : Health

About the author

Leave a Reply

Your email address will not be published. Required fields are marked (required)